Detection of ROS1 rearrangement in non-small cell lung cancer: current and future perspectives
Giulio Rossi,1 Genny Jocollé,2 Antonia Conti,3 Marcello Tiseo,4 Federica Zito Marino,5,6 Giovanni Donati,7 Renato Franco,5,6 Francesca Bono,8 Francesca Barbisan,9 Francesco Facchinetti4,10 1Pathology Unit, 2Oncology Unit, Azienda USL Valle d’Aosta, Regional Hospital “P...
Saved in:
Main Authors: | Rossi G, Jocollé G, Conti A, Tiseo M, Zito Marino F, Donati G, Franco R, Bono F, Barbisan F, Facchinetti F |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/a1ba6c03f55d443a8bc0cfe41a8f2e7e |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Small cell transformation in crizotinib‐resistant ROS1‐rearranged non‐small cell lung cancer with retention of ROS1 fusion: A case report
by: Chi‐Hao Wu, et al.
Published: (2021) -
Profile of entrectinib and its potential in the treatment of ROS1-positive NSCLC: evidence to date
by: Facchinetti F, et al.
Published: (2019) -
Targeting RET-rearranged non-small-cell lung cancer: future prospects
by: Bronte G, et al.
Published: (2019) -
Condensed tannin reactivity inhibition by internal rearrangements: Detection by CP-MAS 13C NMR
by: Navarrete,P, et al.
Published: (2011) -
Amide-Assisted Rearrangement of Hydroxyarylformimidoyl Chloride to Diarylurea
by: Xizhong Song, et al.
Published: (2021)